Bruceine a exerts antitumor effect against colon cancer by accumulating ROS and suppressing PI3K/Akt pathway

Abstract

Bruceine A (BA), a quassic ester from bruceine javanica, regulates diverse intracellular signal transduction pathways and manifests a variety of biological activities, however, its pharmacological mechanism in treating colon cancer (CC) is unclear. In this study, we investigated the anticancer effects of BA on CC cells and the underlying mechanisms. The network pharmacology research indicated that Akt1 and Jun and PI3K/Akt pathways are the predominant targets and critical signaling pathways, respectively, for BA treatment of CC. Meanwhile, molecular docking results implied that BA could conjugate to pivotal proteins in the PI3K/Akt pathway. BA remarkably suppressed the proliferation of CC cells HCT116 and CT26 with 48-h IC50 of 26.12 and 229.26 nM, respectively, and the expression of p-PI3K/p-Akt was restrained by BA at the molecular level as verified by Western blot assay. Further mechanistic studies revealed BA impacted cell cycle-related proteins by regulating the expression of P27 (a protein bridging the PI3K/Akt signaling pathway with cycle-related proteins), arresting the cell cycle in the G2 phase, inhibiting the proliferation of HCT116 and CT26, and facilitated the apoptosis in CC cells by activating the mitochondria-associated apoptosis protein Bax and accumulating reactive oxygen species, in addition to BA apparently inhibited the migration of CC cells. Taken together, our results demonstrated that BA might be a promising chemotherapy drug in the treatment of CC.

A comprehensive view on the apigenin impact on colorectal cancer: Focusing on cellular and molecular mechanisms

“…CC is a predominant gastrointestinal cancer with high death rates and increased morbidity in recent years (Zhang et al, 2023 ). Ineffective treatment interventions and late disease recognition at progressive stages make this cancer a difficult area to manage (Gupta et al, 2019 ).…”

Advances in nanoscale carrier-based approaches to reduce toxicity and enhance efficacy of podophyllotoxin

“…Drugs derived from natural products have been widely employed in the treatment of many major diseases, such as cardiovascular diseases, malignant tumors, and immunologic and infectious diseases [121][122][123][124]. PPT is widely recognized as a broad-spectrum pharmacologically active molecule with remarkable antitumor activity through multiple interaction mechanisms [125].…”